Send us message to learn more about InnoHK
CONTACT US

Centre for Regenerative Medicine and Health, Hong Kong Institute of Science & Innovation, Chinese Academy of Sciences

Centre for Regenerative Medicine and Health, Hong Kong Institute of Science & Innovation, Chinese Academy of Sciences

Pioneering Regenerative Medicine for Next-Gen Human Health Solutions

We will recruit top-notch talent locally, from Mainland China, as well as from overseas thanks to the international environment and unique legal system in Hong Kong. To connect with the renowned biomedical institutions and hospitals in the region, we aim to conduct world-class, cutting-edge collaborative biomedical research.
Professor Duanqing Pei

Co-Director, CRMH, HKISI, CAS,
EMBO Associate Member

Pioneering Regenerative Medicine for Next-Gen Human Health Solutions

Regenerative medicine is rapidly evolving in the fields of biomedicine and health research with the aim of finding new ways to promote self-healing and regeneration of the body using stem cells to build new tissues and organs for restorative treatment of damaged cells, tissues and organs. Expectations for progress in the field and its robust clinical application are high, and there is an increasing recognition that cell-based therapy may play an important role in offsetting age-related diseases.

With this in mind, the Centre for Regenerative Medicine and Health is looking to apply ground-breaking methods to find cures for some of the world’s most chronic fatal diseases such as cancer, and develop new and innovative therapeutics for the world’s growing elderly population. CRMH aims to develop a robust research platform encompassing basic stem cell biology as well as translational sciences, ultimately developing next generation solutions for human health.

Centre for Regenerative Medicine and Health, Hong Kong Institute of Science and Innovation, Chinese Academy of Sciences.

Centre for Regenerative Medicine and Health, Hong Kong Institute of Science and Innovation, Chinese Academy of Sciences.

Co-Directors (middle seated, left to right): Prof. Pei Duanqing, Prof. Pan Guangjin; Core team members (from left back to right): Mr. Gong Jucheng, Prof. Qin Dajiang, Dr. Micky Tortorella, Mr. Eddie Ching, Dr. Wang Yaofeng.

Co-Directors (middle seated, left to right): Prof. Pei Duanqing, Prof. Pan Guangjin; Core team members (from left back to right): Mr. Gong Jucheng, Prof. Qin Dajiang, Dr. Micky Tortorella, Mr. Eddie Ching, Dr. Wang Yaofeng.

Prof. Pei Duanqing, Co-Director, Centre for Regenerative Medicine and Health, HKISI, CAS.

Prof. Pei Duanqing, Co-Director, Centre for Regenerative Medicine and Health, HKISI, CAS.

Advancing Chinese Academy of Sciences' efforts in trailblazing medical research in regenerative medicine, CRMH is leveraging Hong Kong’ s various capabilities and advantages in biomedical sector to set up “Hong Kong standards” for clinical applications of regenerative medicine, including “Good Manufacturing Practice (GMP)” for products that will be accredited and recognised internationally.

In its first five years of work, with the aim to promote the globalization of the research and achievements in regenerative medicine, CRMH will focus on the following areas:

  • Stem cell therapy and genomic editing
  • Developmental biology
  • Drug discovery

In the long run, CRMH is looking forward to fostering regional collaborations in biomedicine and health through China’s Belt and Road Initiative and advancing biomedical research and development to solve key problems in public health in the Greater Bay Area.

Project team members

  • Prof. Duanqing Pei
    Prof. Duanqing Pei

    co-Director

  • Prof. Guangjin Pan
    Prof. Guangjin Pan
    co-Director

In this project

You may also like

Center for Neuromusculoskeletal Restorative Medicine (CNRM)
Center for Neuromusculoskeletal Restorative Medicine (CNRM)
The initiatives for setting up the CNRM, with its thematic & multi- disciplinary nature and collaboration between the two world-class research institutions, present a very unique strength to accelerate R&D breakthrough in neuromusculoskeletal disease. It will certainly strengthen the stature and commitment of Hong Kong as an advanced R&D hub in the region.

OUR TEAM

Professor Patrick Yung, Professor Woody Chan
Microbiota I-Center (MagIC)
Microbiota I-Center (MagIC)
The Microbiota I-Center (MagIC) is determined to harness and empower microbiome into cutting-edge innovations that will transform lives of patients and their families. We are committed to developing novel classes of microbiome diagnostics and therapeutics that will accelerate Hong Kong into a world-class microbiome biotechnology hub.

OUR TEAM

Professor Siew C. Ng, Professor Francis Chan
Centre for Regenerative Medicine and Health, Hong Kong Institute of Science & Innovation, Chinese Academy of Sciences
Centre for Regenerative Medicine and Health, Hong Kong Institute of Science & Innovation, Chinese Academy of Sciences
We will recruit top-notch talent locally, from Mainland China, as well as from overseas thanks to the international environment and unique legal system in Hong Kong. To connect with the renowned biomedical institutions and hospitals in the region, we aim to conduct world-class, cutting-edge collaborative biomedical research.

OUR TEAM

Prof. Duanqing Pei , Prof. Guangjin Pan
Virology
Centre for Virology, Vaccinology and Therapeutics
Centre for Virology, Vaccinology and Therapeutics
Infectious diseases can have devastating health, social and economic consequences locally and globally. By taking this opportunity to set up a research laboratory to conduct collaborative research with world-renowned institutions at InnoHK, CVVT serves as the hub for the incubation of basic research, and the translation of impactful discoveries into applications for the control and prevention of infectious diseases.

OUR TEAM

CVVT ,
Centre for Virology, Vaccinology and Therapeutics

Find your interest